Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence
Clinical trial NCT05062096 · UNKNOWN
Trial details
- NCT number
- NCT05062096
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2023-12-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.